Suppr超能文献

原发性中枢神经系统霍奇金淋巴瘤:病例报告及文献复习。

Primary central nervous system Hodgkin lymphoma: A case report and review of the literature.

机构信息

Department of Neurosurgery, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.

Department of Neurosurgery, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.

出版信息

Neurocirugia (Astur : Engl Ed). 2022 Nov-Dec;33(6):350-355. doi: 10.1016/j.neucie.2021.06.007.

Abstract

Central nervous system (CNS) involvement in the context of relapsed/refractory Hodgkin lymphoma (HL) is a quite rare, but well-known complication. Nevertheless, primary CNS-HL is an exceedingly rare condition, which diagnosis is based on well-defined morphological and immunohistochemical features, in addition to isolated involvement of the CNS. In spite of limited casuistry (just over twenty cases reported in the literature), available data agree that primary and isolated CNS-HL, when treated with a combination of surgery followed by some form of adjuvant therapy (radiotherapy±chemotherapy), carries a better prognosis than those cases with CNS involvement in the context of relapsed/refractory HL or those with CNS non-Hodgkin lymphoma. We herein report a case of a 55-year-old female patient who was diagnosed with primary CNS-HL. The patient was treated with complete surgical resection followed by intrathecal chemotherapy and whole brain radiotherapy (WBRT), showing fourteen months of disease-free survival at the time of this case report. A review of the available literature is also presented.

摘要

中枢神经系统(CNS)受累是复发/难治性霍奇金淋巴瘤(HL)的一种罕见但众所周知的并发症。然而,原发性中枢神经系统 HL 是一种极其罕见的疾病,其诊断基于明确的形态学和免疫组织化学特征,以及中枢神经系统的孤立受累。尽管病例数有限(文献中仅报道了二十多例),但现有数据表明,原发性和孤立性中枢神经系统 HL 通过手术联合辅助治疗(放疗±化疗)治疗,比复发/难治性 HL 中枢神经系统受累或中枢神经系统非霍奇金淋巴瘤患者的预后更好。本文报告了一例 55 岁女性患者,该患者被诊断为原发性中枢神经系统 HL。该患者接受了完全手术切除,随后进行了鞘内化疗和全脑放疗(WBRT),在本病例报告时,患者无疾病生存 14 个月。本文还对现有文献进行了回顾。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验